Back to Search
AMY POLLACK, MD, MPH
Obstetrics & Gynecology Physician
NPI: 1619304516Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
184149(NY)
Research & Publications (20)
Ensuring access to HPV vaccines through integrated services: a reproductive health perspective.
PMID 17242759·Bull World Health Organ·2007
8-other
Interdisciplinary treatment of a severe maxillary aesthetic defect: a case report.
PMID 15112401·Pract Proced Aesthet Dent·2004
5-case
Opening a door to safe abortion: international perspectives on medical abortifacient use.
PMID 10846335·J Am Med Womens Assoc (1972)·2000
8-other
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
PMID 19386445·Int J Radiat Oncol Biol Phys·2009
6-review
Analysis of targeted mutation in DJ-1 on cellular function in primary astrocytes.
PMID 19063952·Toxicol Lett·2009
7-preclinical
Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.
PMID 19598213·Laryngoscope·2009
5-case
Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD.
PMID 18094940·Int Ophthalmol·2009
4-observational
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
PMID 19464826·Int J Radiat Oncol Biol Phys·2009
8-other
Developing a radiation error scoring system to monitor quality control events in a radiation oncology department.
PMID 19111271·J Am Coll Radiol·2009
8-other
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
PMID 19470936·J Clin Oncol·2009
2-rct
Predictive models in external beam radiotherapy for clinically localized prostate cancer.
PMID 19544539·Cancer·2009
6-review
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
PMID 18977097·Int J Radiat Oncol Biol Phys·2009
8-other
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.
PMID 17765406·Int J Radiat Oncol Biol Phys·2008
2-rct
Postprostatectomy radiation therapy for prostate cancer.
PMID 18082584·Semin Radiat Oncol·2008
6-review
Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
PMID 19010821·Mol Cancer Res·2008
8-other
Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel.
PMID 19065273·Mol Vis·2008
8-other
Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy.
PMID 17919840·Int J Radiat Oncol Biol Phys·2008
8-other
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
PMID 18852870·Mol Vis·2008
8-other
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer.
PMID 17968996·Cancer·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 529 WEST 42 STREET, SUITE 7G
NEW YORK, NY 10036 - Phone
- (917) 597-3851
Quick Facts
- NPI
- 1619304516
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile